Table of Contents

1 Market Overview

1.1 Product Overview and Scope of Breakthrough Therapy (BT) Designation

1.2 Classification of Breakthrough Therapy (BT) Designation by Type

1.2.1 Overview: Global Breakthrough Therapy (BT) Designation Revenue by Type: 2015 Versus 2019 Versus 2025

1.2.2 Global Breakthrough Therapy (BT) Designation Revenue Market Share by Type in 2019

1.2.3 Oncology

1.2.4 Infectious Diseases

1.2.5 Rare Diseases

1.2.6 Autoimmune Diseases

1.2.7 Pulmonary Diseases

1.2.8 Neurological Disorders

1.2.9 Others

1.3 Global Breakthrough Therapy (BT) Designation Market by Application

1.3.1 Overview: Global Breakthrough Therapy (BT) Designation Revenue by Application: 2015 Versus 2019 Versus 2025

1.3.2 Hospital

1.3.3 Clinic

1.3.4 Research Institute

1.3.5 Laboratories

1.4 Global Breakthrough Therapy (BT) Designation Market Size and Forecast (2015-2025)

1.5 Global Breakthrough Therapy (BT) Designation Market Size by Regions: 2015 VS 2019 VS 2025

1.6 Global Breakthrough Therapy (BT) Designation Market Size by Regions (2015-2020)

1.7 Global Breakthrough Therapy (BT) Designation Market Size and Forecast by Regions (2020-2025)

1.7.1 North America Breakthrough Therapy (BT) Designation Status and Prospect (2015-2025)

1.7.2 Europe Breakthrough Therapy (BT) Designation Status and Prospect (2015-2025)

1.7.3 Asia Breakthrough Therapy (BT) Designation Status and Prospect (2015-2025)

1.7.4 South America Breakthrough Therapy (BT) Designation Status and Prospect (2015-2025)

1.7.5 Middle East & Africa Breakthrough Therapy (BT) Designation Status and Prospect (2015-2025)

2 Company Profiles

2.1 Roche

2.1.1 Roche Details

2.1.2 Roche Major Business and Total Revenue (Financial Highlights) Analysis

2.1.3 Roche SWOT Analysis

2.1.4 Roche Product and Services

2.1.5 Roche Breakthrough Therapy (BT) Designation Revenue, Gross Margin and Market Share (2018-2019)

2.2 Sanofi

2.2.1 Sanofi Details

2.2.2 Sanofi Major Business and Total Revenue (Financial Highlights) Analysis

2.2.3 Sanofi SWOT Analysis

2.2.4 Sanofi Product and Services

2.2.5 Sanofi Breakthrough Therapy (BT) Designation Revenue, Gross Margin and Market Share (2018-2019)

2.3 Janssen

2.3.1 Janssen Details

2.3.2 Janssen Major Business and Total Revenue (Financial Highlights) Analysis

2.3.3 Janssen SWOT Analysis

2.3.4 Janssen Product and Services

2.3.5 Janssen Breakthrough Therapy (BT) Designation Revenue, Gross Margin and Market Share (2018-2019)

2.4 Abbvie

2.4.1 Abbvie Details

2.4.2 Abbvie Major Business and Total Revenue (Financial Highlights) Analysis

2.4.3 Abbvie SWOT Analysis

2.4.4 Abbvie Product and Services

2.4.5 Abbvie Breakthrough Therapy (BT) Designation Revenue, Gross Margin and Market Share (2018-2019)

2.5 Gilead

2.5.1 Gilead Details

2.5.2 Gilead Major Business and Total Revenue (Financial Highlights) Analysis

2.5.3 Gilead SWOT Analysis

2.5.4 Gilead Product and Services

2.5.5 Gilead Breakthrough Therapy (BT) Designation Revenue, Gross Margin and Market Share (2018-2019)

2.6 Novartis International AG

2.6.1 Novartis International AG Details

2.6.2 Novartis International AG Major Business and Total Revenue (Financial Highlights) Analysis

2.6.3 Novartis International AG SWOT Analysis

2.6.4 Novartis International AG Product and Services

2.6.5 Novartis International AG Breakthrough Therapy (BT) Designation Revenue, Gross Margin and Market Share (2018-2019)

2.7 Acadia

2.7.1 Acadia Details

2.7.2 Acadia Major Business and Total Revenue (Financial Highlights) Analysis

2.7.3 Acadia SWOT Analysis

2.7.4 Acadia Product and Services

2.7.5 Acadia Breakthrough Therapy (BT) Designation Revenue, Gross Margin and Market Share (2018-2019)

2.8 Eli Lilly

2.8.1 Eli Lilly Details

2.8.2 Eli Lilly Major Business and Total Revenue (Financial Highlights) Analysis

2.8.3 Eli Lilly SWOT Analysis

2.8.4 Eli Lilly Product and Services

2.8.5 Eli Lilly Breakthrough Therapy (BT) Designation Revenue, Gross Margin and Market Share (2018-2019)

2.9 BMS

2.9.1 BMS Details

2.9.2 BMS Major Business and Total Revenue (Financial Highlights) Analysis

2.9.3 BMS SWOT Analysis

2.9.4 BMS Product and Services

2.9.5 BMS Breakthrough Therapy (BT) Designation Revenue, Gross Margin and Market Share (2018-2019)

2.10 Regeneron

2.10.1 Regeneron Details

2.10.2 Regeneron Major Business and Total Revenue (Financial Highlights) Analysis

2.10.3 Regeneron SWOT Analysis

2.10.4 Regeneron Product and Services

2.10.5 Regeneron Breakthrough Therapy (BT) Designation Revenue, Gross Margin and Market Share (2018-2019)

2.11 Vertex

2.11.1 Vertex Details

2.11.2 Vertex Major Business and Total Revenue (Financial Highlights) Analysis

2.11.3 Vertex SWOT Analysis

2.11.4 Vertex Product and Services

2.11.5 Vertex Breakthrough Therapy (BT) Designation Revenue, Gross Margin and Market Share (2018-2019)

2.12 Jazz Pharmaceuticals

2.12.1 Jazz Pharmaceuticals Details

2.12.2 Jazz Pharmaceuticals Major Business and Total Revenue (Financial Highlights) Analysis

2.12.3 Jazz Pharmaceuticals SWOT Analysis

2.12.4 Jazz Pharmaceuticals Product and Services

2.12.5 Jazz Pharmaceuticals Breakthrough Therapy (BT) Designation Revenue, Gross Margin and Market Share (2018-2019)

2.13 Boehringer Ingelheim

2.13.1 Boehringer Ingelheim Details

2.13.2 Boehringer Ingelheim Major Business and Total Revenue (Financial Highlights) Analysis

2.13.3 Boehringer Ingelheim SWOT Analysis

2.13.4 Boehringer Ingelheim Product and Services

2.13.5 Boehringer Ingelheim Breakthrough Therapy (BT) Designation Revenue, Gross Margin and Market Share (2018-2019)

2.14 Eisai

2.14.1 Eisai Details

2.14.2 Eisai Major Business and Total Revenue (Financial Highlights) Analysis

2.14.3 Eisai SWOT Analysis

2.14.4 Eisai Product and Services

2.14.5 Eisai Breakthrough Therapy (BT) Designation Revenue, Gross Margin and Market Share (2018-2019)

2.15 Alexion

2.15.1 Alexion Details

2.15.2 Alexion Major Business and Total Revenue (Financial Highlights) Analysis

2.15.3 Alexion SWOT Analysis

2.15.4 Alexion Product and Services

2.15.5 Alexion Breakthrough Therapy (BT) Designation Revenue, Gross Margin and Market Share (2018-2019)

2.16 GlaxoSmithKline

2.16.1 GlaxoSmithKline Details

2.16.2 GlaxoSmithKline Major Business and Total Revenue (Financial Highlights) Analysis

2.16.3 GlaxoSmithKline SWOT Analysis

2.16.4 GlaxoSmithKline Product and Services

2.16.5 GlaxoSmithKline Breakthrough Therapy (BT) Designation Revenue, Gross Margin and Market Share (2018-2019)

2.17 Amgen

2.17.1 Amgen Details

2.17.2 Amgen Major Business and Total Revenue (Financial Highlights) Analysis

2.17.3 Amgen SWOT Analysis

2.17.4 Amgen Product and Services

2.17.5 Amgen Breakthrough Therapy (BT) Designation Revenue, Gross Margin and Market Share (2018-2019)

2.18 Exelixis

2.18.1 Exelixis Details

2.18.2 Exelixis Major Business and Total Revenue (Financial Highlights) Analysis

2.18.3 Exelixis SWOT Analysis

2.18.4 Exelixis Product and Services

2.18.3 Exelixis Breakthrough Therapy (BT) Designation Revenue, Gross Margin and Market Share (2018-2019)

2.19 Merck

2.19.1 Merck Details

2.19.2 Merck Major Business and Total Revenue (Financial Highlights) Analysis

2.19.3 Merck SWOT Analysis

2.19.4 Merck Product and Services

2.19.5 Merck Breakthrough Therapy (BT) Designation Revenue, Gross Margin and Market Share (2018-2019)

2.20 AstraZeneca

2.20.1 AstraZeneca Details

2.20.2 AstraZeneca Major Business and Total Revenue (Financial Highlights) Analysis

2.20.3 AstraZeneca SWOT Analysis

2.20.4 AstraZeneca Product and Services

2.20.5 AstraZeneca Breakthrough Therapy (BT) Designation Revenue, Gross Margin and Market Share (2018-2019)

2.21 Takeda

2.21.1 Takeda Details

2.21.2 Takeda Major Business and Total Revenue (Financial Highlights) Analysis

2.21.3 Takeda SWOT Analysis

2.21.4 Takeda Product and Services

2.21.5 Takeda Breakthrough Therapy (BT) Designation Revenue, Gross Margin and Market Share (2018-2019)

2.22 Pfizer

2.22.1 Pfizer Details

2.22.2 Pfizer Major Business and Total Revenue (Financial Highlights) Analysis

2.22.3 Pfizer SWOT Analysis

2.22.4 Pfizer Product and Services

2.22.5 Pfizer Breakthrough Therapy (BT) Designation Revenue, Gross Margin and Market Share (2018-2019)

3 Market Competition, by Players

3.1 Global Breakthrough Therapy (BT) Designation Market Size by Players (2015-2020)

3.2 China Breakthrough Therapy (BT) Designation Market Size by Players (2015-2020)

3.3 Market Concentration Rate

3.3.1 Top 5 Breakthrough Therapy (BT) Designation Players Market Share

3.3.2 Top 10 Breakthrough Therapy (BT) Designation Players Market Share

4 North America Market Size and Forecast by Countries

4.1 North America Breakthrough Therapy (BT) Designation Market Size by Countries (2015-2020)

4.2 North America Breakthrough Therapy (BT) Designation Market Size and Forecast by Countries (2015-2026)

4.3 United States Breakthrough Therapy (BT) Designation Market Size and Forecast (2015-2025)

4.4 Canada Breakthrough Therapy (BT) Designation Market Size and Forecast (2015-2025)

4.5 Mexico Breakthrough Therapy (BT) Designation Market Size and Forecast (2015-2025)

5 Europe Market Size and Forecast by Countries

5.1 Europe Breakthrough Therapy (BT) Designation Market Size by Countries (2015-2020)

5.2 Europe Breakthrough Therapy (BT) Designation Market Size and Forecast by Countries (2015-2026)

5.3 Germany Breakthrough Therapy (BT) Designation Market Size and Forecast (2015-2025)

5.4 France Breakthrough Therapy (BT) Designation Market Size and Forecast (2015-2025)

5.5 UK Breakthrough Therapy (BT) Designation Market Size and Forecast (2015-2025)

5.6 Russia Breakthrough Therapy (BT) Designation Market Size and Forecast (2015-2025)

5.7 Italy Breakthrough Therapy (BT) Designation Market Size and Forecast (2015-2025)

6 Asia-Pacific Market Size and Forecast by Countries

6.1 Asia-Pacific Breakthrough Therapy (BT) Designation Market Size by Regions (2015-2020)

6.2 Asia-Pacific Breakthrough Therapy (BT) Designation Market Size and Forecast by Regions (2015-2026)

6.3 China Breakthrough Therapy (BT) Designation Market Size and Forecast (2015-2025)

6.4 Japan Breakthrough Therapy (BT) Designation Market Size and Forecast (2015-2025)

6.5 Korea Breakthrough Therapy (BT) Designation Market Size and Forecast (2015-2025)

6.6 India Breakthrough Therapy (BT) Designation Market Size and Forecast (2015-2025)

6.7 Southeast Asia Breakthrough Therapy (BT) Designation Market Size and Forecast (2015-2025)

7 South America Market Size and Forecast by Countries

7.1 South America Breakthrough Therapy (BT) Designation Market Size by Countries (2015-2020)

7.2 South America Breakthrough Therapy (BT) Designation Market Size and Forecast by Countries (2015-2026)

7.3 Brazil Breakthrough Therapy (BT) Designation Market Size and Forecast (2015-2025)

7.4 Argentina Breakthrough Therapy (BT) Designation Market Size and Forecast (2015-2025)

8 Middle East & Africa Market Size and Forecast by Countries

8.1 Middle East & Africa Breakthrough Therapy (BT) Designation Revenue by Regions (2015-2020)

8.2 Middle East & Africa Breakthrough Therapy (BT) Designation Market Size and Forecast by Countries (2015-2026)

8.3 Saudi Arabia Breakthrough Therapy (BT) Designation Market Size and Forecast (2015-2025)

8.4 UAE Breakthrough Therapy (BT) Designation Market Size and Forecast (2015-2025)

8.5 Egypt Breakthrough Therapy (BT) Designation Market Size and Forecast (2015-2025)

8.6 South Africa Breakthrough Therapy (BT) Designation Market Size and Forecast (2015-2025)

9 Market Size Segment by Type

9.1 Global Breakthrough Therapy (BT) Designation Market Size and Forecast by Type (2015-2025)

9.1.1 Global Breakthrough Therapy (BT) Designation Market Size by Type (2015-2020)

9.1.2 Global Breakthrough Therapy (BT) Designation Market Size Forecast by Type (2020-2025)

9.2 China Breakthrough Therapy (BT) Designation Market Size and Forecast by Type (2015-2025)

9.2.1 China Breakthrough Therapy (BT) Designation Market Size by Type (2015-2020)

9.2.2 China Breakthrough Therapy (BT) Designation Market Size Forecast by Type (2020-2025)

10 Market Size Segment by Application

10.1 Global Breakthrough Therapy (BT) Designation Market Size and Forecast by Application (2015-2025)

10.1.1 Global Breakthrough Therapy (BT) Designation Market Size by Application (2015-2020)

10.1.2 Global Breakthrough Therapy (BT) Designation Market Size Forecast by Application (2020-2025)

10.2 China Breakthrough Therapy (BT) Designation Market Size and Forecast by Application (2015-2025)

10.2.1 China Breakthrough Therapy (BT) Designation Market Size by Application (2015-2020)

10.2.2 China Breakthrough Therapy (BT) Designation Market Size Forecast by Application (2020-2025)

11 Research Findings and Conclusion

12 Appendix

12.1 Methodology

12.2 Data Source

12.3 Disclaimer

12.4 About US

List of Tables

Table 1. Global Breakthrough Therapy (BT) Designation Revenue (USD Million) by Type: 2015 Versus 2019 Versus 2025

Table 2. Breakdown of Breakthrough Therapy (BT) Designation by Company Type (Tier 1, Tier 2 and Tier 3)

Table 3. Global Breakthrough Therapy (BT) Designation Revenue (USD Million) by Application: 2015 Versus 2019 Versus 2025

Table 4. Global Market Breakthrough Therapy (BT) Designation Market Size (USD Million) Comparison by Regions (2020-2025)

Table 5. Global Breakthrough Therapy (BT) Designation Revenue (USD Million) by Regions (2015-2020)

Table 6. Global Breakthrough Therapy (BT) Designation Revenue Share by Regions (2015-2020)

Table 7. Global Breakthrough Therapy (BT) Designation Revenue (USD Million) by Regions (2020-2025)

Table 8. Global Breakthrough Therapy (BT) Designation Revenue Market Share by Regions (2020-2025)

Table 9. Roche Corporate Information, Location and Competitors

Table 10. Roche Major Business

Table 11. Roche Breakthrough Therapy (BT) Designation Total Revenue (USD Million) (2017-2018)

Table 12. Roche SWOT Analysis

Table 13. Roche Breakthrough Therapy (BT) Designation Product and Solutions

Table 14. Roche Breakthrough Therapy (BT) Designation Revenue (USD Million), Gross Margin and Market Share (2018-2019)

Table 15. Sanofi Corporate Information, Location and Competitors

Table 16. Sanofi Major Business

Table 17. Sanofi Breakthrough Therapy (BT) Designation Total Revenue (USD Million) (2018-2019)

Table 18. Sanofi SWOT Analysis

Table 19. Sanofi Breakthrough Therapy (BT) Designation Product and Solutions

Table 20. Sanofi Breakthrough Therapy (BT) Designation Revenue (USD Million), Gross Margin and Market Share (2018-2019)

Table 21. Janssen Corporate Information, Location and Competitors

Table 22. Janssen Major Business

Table 23. Janssen Breakthrough Therapy (BT) Designation Total Revenue (USD Million) (2017-2018)

Table 24. Janssen SWOT Analysis

Table 25. Janssen Breakthrough Therapy (BT) Designation Product and Solutions

Table 26. Janssen Breakthrough Therapy (BT) Designation Revenue (USD Million), Gross Margin and Market Share (2018-2019)

Table 27. Abbvie Corporate Information, Location and Competitors

Table 28. Abbvie Major Business

Table 29. Abbvie Breakthrough Therapy (BT) Designation Total Revenue (USD Million) (2017-2018)

Table 30. Abbvie SWOT Analysis

Table 31. Abbvie Breakthrough Therapy (BT) Designation Product and Solutions

Table 32. Abbvie Breakthrough Therapy (BT) Designation Revenue (USD Million), Gross Margin and Market Share (2018-2019)

Table 33. Gilead Corporate Information, Location and Competitors

Table 34. Gilead Major Business

Table 35. Gilead Breakthrough Therapy (BT) Designation Total Revenue (USD Million) (2017-2018)

Table 36. Gilead SWOT Analysis

Table 37. Gilead Breakthrough Therapy (BT) Designation Product and Solutions

Table 38. Gilead Breakthrough Therapy (BT) Designation Revenue (USD Million), Gross Margin and Market Share (2018-2019)

Table 39. Novartis International AG Corporate Information, Location and Competitors

Table 40. Novartis International AG Major Business

Table 41. Novartis International AG Breakthrough Therapy (BT) Designation Total Revenue (USD Million) (2017-2018)

Table 42. Novartis International AG SWOT Analysis

Table 43. Novartis International AG Breakthrough Therapy (BT) Designation Product and Solutions

Table 44. Novartis International AG Breakthrough Therapy (BT) Designation Revenue (USD Million), Gross Margin and Market Share (2018-2019)

Table 45. Acadia Corporate Information, Location and Competitors

Table 46. Acadia Major Business

Table 47. Acadia Breakthrough Therapy (BT) Designation Total Revenue (USD Million) (2017-2018)

Table 48. Acadia SWOT Analysis

Table 49. Acadia Breakthrough Therapy (BT) Designation Product and Solutions

Table 50. Acadia Breakthrough Therapy (BT) Designation Revenue (USD Million), Gross Margin and Market Share (2018-2019)

Table 51. Eli Lilly Corporate Information, Location and Competitors

Table 52. Eli Lilly Major Business

Table 53. Eli Lilly Breakthrough Therapy (BT) Designation Total Revenue (USD Million) (2017-2018)

Table 54. Eli Lilly SWOT Analysis

Table 55. Eli Lilly Breakthrough Therapy (BT) Designation Product and Solutions

Table 56. Eli Lilly Breakthrough Therapy (BT) Designation Revenue (USD Million), Gross Margin and Market Share (2018-2019)

Table 57. BMS Corporate Information, Location and Competitors

Table 58. BMS Major Business

Table 59. BMS Breakthrough Therapy (BT) Designation Total Revenue (USD Million) (2017-2018)

Table 60. BMS SWOT Analysis

Table 61. BMS Breakthrough Therapy (BT) Designation Product and Solutions

Table 62. BMS Breakthrough Therapy (BT) Designation Revenue (USD Million), Gross Margin and Market Share (2018-2019)

Table 63. Regeneron Corporate Information, Location and Competitors

Table 64. Regeneron Major Business

Table 65. Regeneron Breakthrough Therapy (BT) Designation Total Revenue (USD Million) (2017-2018)

Table 66. Regeneron SWOT Analysis

Table 67. Regeneron Breakthrough Therapy (BT) Designation Product and Solutions

Table 68. Regeneron Breakthrough Therapy (BT) Designation Revenue (USD Million), Gross Margin and Market Share (2018-2019)

Table 69. Vertex Corporate Information, Location and Competitors

Table 70. Vertex Major Business

Table 71. Vertex Breakthrough Therapy (BT) Designation Total Revenue (USD Million) (2017-2018)

Table 72. Vertex SWOT Analysis

Table 73. Vertex Breakthrough Therapy (BT) Designation Product and Solutions

Table 74. Vertex Breakthrough Therapy (BT) Designation Revenue (USD Million), Gross Margin and Market Share (2018-2019)

Table 75. Jazz Pharmaceuticals Corporate Information, Location and Competitors

Table 76. Jazz Pharmaceuticals Major Business

Table 77. Jazz Pharmaceuticals Breakthrough Therapy (BT) Designation Total Revenue (USD Million) (2017-2018)

Table 78. Jazz Pharmaceuticals SWOT Analysis

Table 79. Jazz Pharmaceuticals Breakthrough Therapy (BT) Designation Product and Solutions

Table 80. Jazz Pharmaceuticals Breakthrough Therapy (BT) Designation Revenue (USD Million), Gross Margin and Market Share (2018-2019)

Table 81. Boehringer Ingelheim Corporate Information, Location and Competitors

Table 82. Boehringer Ingelheim Major Business

Table 83. Boehringer Ingelheim Breakthrough Therapy (BT) Designation Total Revenue (USD Million) (2017-2018)

Table 84. Boehringer Ingelheim SWOT Analysis

Table 85. Boehringer Ingelheim Breakthrough Therapy (BT) Designation Product and Solutions

Table 86. Boehringer Ingelheim Breakthrough Therapy (BT) Designation Revenue (USD Million), Gross Margin and Market Share (2018-2019)

Table 87. Eisai Corporate Information, Location and Competitors

Table 88. Eisai Major Business

Table 89. Eisai Breakthrough Therapy (BT) Designation Total Revenue (USD Million) (2017-2018)

Table 90. Eisai SWOT Analysis

Table 91. Eisai Breakthrough Therapy (BT) Designation Product and Solutions

Table 92. Eisai Breakthrough Therapy (BT) Designation Revenue (USD Million), Gross Margin and Market Share (2018-2019)

Table 93. Alexion Corporate Information, Location and Competitors

Table 94. Alexion Major Business

Table 95. Alexion Breakthrough Therapy (BT) Designation Total Revenue (USD Million) (2017-2018)

Table 96. Alexion SWOT Analysis

Table 97. Alexion Breakthrough Therapy (BT) Designation Product and Solutions

Table 98. Alexion Breakthrough Therapy (BT) Designation Revenue (USD Million), Gross Margin and Market Share (2018-2019)

Table 99. GlaxoSmithKline Corporate Information, Location and Competitors

Table 100. GlaxoSmithKline Major Business

Table 101. GlaxoSmithKline Breakthrough Therapy (BT) Designation Total Revenue (USD Million) (2017-2018)

Table 102. GlaxoSmithKline SWOT Analysis

Table 103. GlaxoSmithKline Breakthrough Therapy (BT) Designation Product and Solutions

Table 104. GlaxoSmithKline Breakthrough Therapy (BT) Designation Revenue (USD Million), Gross Margin and Market Share (2018-2019)

Table 105. Amgen Corporate Information, Location and Competitors

Table 106. Amgen Major Business

Table 107. Amgen Breakthrough Therapy (BT) Designation Total Revenue (USD Million) (2017-2018)

Table 108. Amgen SWOT Analysis

Table 109. Amgen Breakthrough Therapy (BT) Designation Product and Solutions

Table 110. Amgen Breakthrough Therapy (BT) Designation Revenue (USD Million), Gross Margin and Market Share (2018-2019)

Table 111. Exelixis Breakthrough Therapy (BT) Designation Type and Application

Table 112. Exelixis Major Business

Table 113. Exelixis Breakthrough Therapy (BT) Designation Total Revenue (USD Million) (2017-2018)

Table 114. Exelixis SWOT Analysis

Table 115. Exelixis Breakthrough Therapy (BT) Designation Product and Solutions

Table 116. Exelixis Breakthrough Therapy (BT) Designation Revenue (USD Million), Gross Margin and Market Share (2018-2019)

Table 117. Merck Corporate Information, Location and Competitors

Table 118. Merck Major Business

Table 119. Merck Breakthrough Therapy (BT) Designation Total Revenue (USD Million) (2017-2018)

Table 120. Merck SWOT Analysis

Table 121. Merck Breakthrough Therapy (BT) Designation Product and Solutions

Table 122. Merck Breakthrough Therapy (BT) Designation Revenue (USD Million), Gross Margin and Market Share (2018-2019)

Table 123. AstraZeneca Corporate Information, Location and Competitors

Table 124. AstraZeneca Major Business

Table 125. AstraZeneca Breakthrough Therapy (BT) Designation Total Revenue (USD Million) (2017-2018)

Table 126. AstraZeneca SWOT Analysis

Table 127. AstraZeneca Breakthrough Therapy (BT) Designation Product and Solutions

Table 128. AstraZeneca Breakthrough Therapy (BT) Designation Revenue (USD Million), Gross Margin and Market Share (2018-2019)

Table 129. Takeda Corporate Information, Location and Competitors

Table 130. Takeda Major Business

Table 131. Takeda Breakthrough Therapy (BT) Designation Total Revenue (USD Million) (2017-2018)

Table 132. Takeda SWOT Analysis

Table 133. Takeda Breakthrough Therapy (BT) Designation Product and Solutions

Table 134. Takeda Breakthrough Therapy (BT) Designation Revenue (USD Million), Gross Margin and Market Share (2018-2019)

Table 135. Pfizer Corporate Information, Location and Competitors

Table 136. Pfizer Major Business

Table 137. Pfizer Breakthrough Therapy (BT) Designation Total Revenue (USD Million) (2017-2018)

Table 138. Pfizer SWOT Analysis

Table 139. Pfizer Breakthrough Therapy (BT) Designation Product and Solutions

Table 140. Pfizer Breakthrough Therapy (BT) Designation Revenue (USD Million), Gross Margin and Market Share (2018-2019)

Table 141. Global Breakthrough Therapy (BT) Designation Revenue (USD Million) by Players (2015-2020)

Table 142. Global Breakthrough Therapy (BT) Designation Revenue Share by Players (2015-2020)

Table 143. Key Players Breakthrough Therapy (BT) Designation Revenue (USD Million) in China (2015-2020)

Table 144. Key Players Breakthrough Therapy (BT) Designation Revenue Share in China (2015-2020)

Table 145. North America Breakthrough Therapy (BT) Designation Revenue (USD Million) by Countries (2015-2020)

Table 146. North America Breakthrough Therapy (BT) Designation Revenue Market Share by Countries (2015-2020)

Table 147. North America Breakthrough Therapy (BT) Designation Revenue (USD Million) by Countries (2020-2026)

Table 148. North America Breakthrough Therapy (BT) Designation Revenue Market Share by Countries (2020-2026)

Table 149. Europe Breakthrough Therapy (BT) Designation Revenue (USD Million) by Countries (2015-2020)

Table 150. Europe Breakthrough Therapy (BT) Designation Revenue Market Share by Countries (2015-2020)

Table 151. Europe Breakthrough Therapy (BT) Designation Revenue (USD Million) by Countries (2020-2026)

Table 152. Europe Breakthrough Therapy (BT) Designation Revenue Market Share by Countries (2020-2026)

Table 153. Asia-Pacific Breakthrough Therapy (BT) Designation Revenue (USD Million) by Countries (2015-2020)

Table 154. Asia-Pacific Breakthrough Therapy (BT) Designation Revenue Market Share by Countries (2015-2020)

Table 155. Asia-Pacific Breakthrough Therapy (BT) Designation Revenue (USD Million) by Countries (2020-2026)

Table 156. Asia-Pacific Breakthrough Therapy (BT) Designation Revenue Market Share by Countries (2020-2026)

Table 157. South America Breakthrough Therapy (BT) Designation Revenue (USD Million) by Countries (2015-2020)

Table 158. South America Breakthrough Therapy (BT) Designation Revenue Market Share by Countries (2015-2020)

Table 159. South America Breakthrough Therapy (BT) Designation Revenue (USD Million) by Countries (2020-2026)

Table 160. South America Breakthrough Therapy (BT) Designation Revenue Market Share by Countries (2020-2026)

Table 161. Middle East & Africa Breakthrough Therapy (BT) Designation Revenue (USD Million) by Countries (2015-2020)

Table 162. Middle East & Africa Breakthrough Therapy (BT) Designation Revenue Market Share by Countries (2015-2020)

Table 163. Middle East & Africa Breakthrough Therapy (BT) Designation Revenue (USD Million) by Countries (2020-2026)

Table 164. Middle East & Africa Breakthrough Therapy (BT) Designation Revenue Market Share by Countries (2020-2026)

Table 165. Global Breakthrough Therapy (BT) Designation Revenue (USD Million) by Type (2015-2020)

Table 166. Global Breakthrough Therapy (BT) Designation Revenue Share by Type (2015-2020)

Table 167. Global Breakthrough Therapy (BT) Designation Revenue Forecast by Type (2020-2025)

Table 168. Global Breakthrough Therapy (BT) Designation Market Share Forecast by Type (2020-2025)

Table 169. China Breakthrough Therapy (BT) Designation Revenue (USD Million) by Type (2015-2020)

Table 170. China Breakthrough Therapy (BT) Designation Revenue Share by Type (2015-2020)

Table 171. China Breakthrough Therapy (BT) Designation Revenue Forecast by Type (2020-2025)

Table 172. China Breakthrough Therapy (BT) Designation Market Share Forecast by Type (2020-2025)

Table 173. Global Breakthrough Therapy (BT) Designation Revenue (USD Million) by Application (2015-2020)

Table 174. Global Breakthrough Therapy (BT) Designation Revenue Share by Application (2015-2020)

Table 175. Global Breakthrough Therapy (BT) Designation Revenue Forecast by Application (2020-2025)

Table 176. Global Breakthrough Therapy (BT) Designation Market Share Forecast by Application (2020-2025)

Table 177. China Breakthrough Therapy (BT) Designation Revenue (USD Million) by Application (2015-2020)

Table 178. China Breakthrough Therapy (BT) Designation Revenue Share by Application (2015-2020)

Table 179. China Breakthrough Therapy (BT) Designation Revenue Forecast by Application (2020-2025)

Table 180. China Breakthrough Therapy (BT) Designation Market Share Forecast by Application (2020-2025)

List of Figures

Figure 1. Breakthrough Therapy (BT) Designation Picture

Figure 2. Global Breakthrough Therapy (BT) Designation Market Share by Company Type (Tier 1, Tier 2 and Tier 3)

Figure 3. Global Breakthrough Therapy (BT) Designation Revenue Market Share by Type in 2019

Figure 4. Oncology Picture

Figure 5. Infectious Diseases Picture

Figure 6. Rare Diseases Picture

Figure 7. Autoimmune Diseases Picture

Figure 8. Pulmonary Diseases Picture

Figure 9. Neurological Disorders Picture

Figure 10. Others Picture

Figure 11. Breakthrough Therapy (BT) Designation Revenue Market Share by Application in 2019

Figure 12. Hospital Picture

Figure 13. Clinic Picture

Figure 14. Research Institute Picture

Figure 15. Laboratories Picture

Figure 16. Global Breakthrough Therapy (BT) Designation Revenue and Growth Rate (2015-2025) (USD Million)

Figure 17. Global Breakthrough Therapy (BT) Designation Market Size Share by Regions (2015-2025)

Figure 18. Global Breakthrough Therapy (BT) Designation Market Size Share by Regions in 2019

Figure 19. Global Breakthrough Therapy (BT) Designation Revenue Market Share by Regions (2020-2025)

Figure 20. North America Breakthrough Therapy (BT) Designation Revenue (USD Million) and Growth Rate (2015-2025)

Figure 21. Europe Breakthrough Therapy (BT) Designation Revenue (USD Million) and Growth Rate (2015-2025)

Figure 22. Asia-Pacific Breakthrough Therapy (BT) Designation Revenue (USD Million) and Growth Rate (2015-2025)

Figure 23. South America Breakthrough Therapy (BT) Designation Revenue (USD Million) and Growth Rate (2015-2025)

Figure 24. Middle East & Africa Breakthrough Therapy (BT) Designation Revenue (USD Million) and Growth Rate (2015-2025)

Figure 25. Global Breakthrough Therapy (BT) Designation Revenue Share by Players in 2019

Figure 26. Global Top 5 Players Breakthrough Therapy (BT) Designation Revenue Market Share in 2019

Figure 27. Top 10 Players Breakthrough Therapy (BT) Designation Revenue Market Share in Global Market in 2019

Figure 28. Global Breakthrough Therapy (BT) Designation Market Size (USD Million) by Type (2015-2025)

Figure 29. Global Breakthrough Therapy (BT) Designation Market Size Share by Application (2015-2025)

Figure 30. North America Breakthrough Therapy (BT) Designation Market Size Share by Countries (2015-2025)

Figure 31. North America Breakthrough Therapy (BT) Designation Market Size Share by Countries in 2019

Figure 32. United States Breakthrough Therapy (BT) Designation Market Size (USD Million) and Forecast (2015-2025)

Figure 33. Canada Breakthrough Therapy (BT) Designation Market Size (USD Million) and Forecast (2015-2025)

Figure 34. Mexico Breakthrough Therapy (BT) Designation Market Size (USD Million) and Forecast (2015-2025)

Figure 35. Europe Breakthrough Therapy (BT) Designation Market Size Share by Countries (2015-2025)

Figure 36. Europe Breakthrough Therapy (BT) Designation Market Size Share by Countries in 2019

Figure 37. Germany Breakthrough Therapy (BT) Designation Market Size (USD Million) and Forecast (2015-2025)

Figure 38. France Breakthrough Therapy (BT) Designation Market Size (USD Million) and Forecast (2015-2025)

Figure 39. Russia Breakthrough Therapy (BT) Designation Market Size (USD Million) and Forecast (2015-2025)

Figure 40. Italy Breakthrough Therapy (BT) Designation Market Size (USD Million) and Forecast (2015-2025)

Figure 41. Spain Breakthrough Therapy (BT) Designation Market Size (USD Million) and Forecast (2015-2025)

Figure 42. UK Breakthrough Therapy (BT) Designation Market Size (USD Million) and Forecast (2015-2025)

Figure 43. Asia Breakthrough Therapy (BT) Designation Market Size Share by Countries (2015-2025)

Figure 44. Asia Breakthrough Therapy (BT) Designation Market Size Share by Countries in 2019

Figure 45. China Breakthrough Therapy (BT) Designation Market Size (USD Million) and Forecast (2015-2025)

Figure 46. Japan Breakthrough Therapy (BT) Designation Market Size (USD Million) and Forecast (2015-2025)

Figure 47. Korea Breakthrough Therapy (BT) Designation Market Size (USD Million) and Forecast (2015-2025)

Figure 48. India Breakthrough Therapy (BT) Designation Market Size (USD Million) and Forecast (2015-2025)

Figure 49. Southeast Asia Breakthrough Therapy (BT) Designation Market Size (USD Million) and Forecast (2015-2025)

Figure 50. South America Breakthrough Therapy (BT) Designation Market Size Share by Countries (2015-2025)

Figure 51. South America Breakthrough Therapy (BT) Designation Market Size Share by Countries in 2019

Figure 52. Brazil Breakthrough Therapy (BT) Designation Market Size (USD Million) and Forecast (2015-2025)

Figure 53. Argentina Breakthrough Therapy (BT) Designation Market Size (USD Million) and Forecast (2015-2025)

Figure 54. Middle East & Africa Breakthrough Therapy (BT) Designation Market Size Share by Countries (2015-2025)

Figure 55. Middle East & Africa Breakthrough Therapy (BT) Designation Market Size Share by Countries in 2019

Figure 56. Saudi Arabia Breakthrough Therapy (BT) Designation Market Size (USD Million) and Forecast (2015-2025)

Figure 57. UAE Breakthrough Therapy (BT) Designation Market Size (USD Million) and Forecast (2015-2025)

Figure 58. Egypt Breakthrough Therapy (BT) Designation Market Size (USD Million) and Forecast (2015-2025)

Figure 59. South Africa Breakthrough Therapy (BT) Designation Market Size (USD Million) and Forecast (2015-2025)

Figure 60. Global Breakthrough Therapy (BT) Designation Revenue Share by Type (2015-2020)

Figure 61. China Breakthrough Therapy (BT) Designation Revenue Share by Type (2015-2020)

Figure 62. Global Breakthrough Therapy (BT) Designation Revenue Share by Application (2015-2020)

Figure 63. China Breakthrough Therapy (BT) Designation Revenue Share by Application (2015-2020)